Anteris Technologies Global Corp.AVREarnings & Financial Report
Anteris Technologies Global Corp is a medical technology firm specializing in innovative structural heart care solutions. It develops and commercializes bioprosthetic heart valves and transcatheter intervention products, serving healthcare providers across North America, Europe, and Asia-Pacific, with core focus on cardiac surgery and interventional cardiology segments.
AVR Q4 FY2025 Key Financial Metrics
Revenue
$310.0K
Gross Profit
$219.0K
Operating Profit
$-29.0M
Net Profit
$-29.2M
Gross Margin
70.6%
Operating Margin
-9343.5%
Net Margin
-9420.0%
YoY Growth
N/A
EPS
$-0.74
Anteris Technologies Global Corp. Q4 FY2025 Financial Summary
Anteris Technologies Global Corp. reported revenue of $310.0K for Q4 FY2025, with a net profit of $-29.2M (-9420.0% margin). Cost of goods sold was $91.0K, operating expenses totaled $29.2M.
Key Financial Metrics
| Total Revenue | $310.0K |
|---|---|
| Net Profit | $-29.2M |
| Gross Margin | 70.6% |
| Operating Margin | -9343.5% |
| Report Period | Q4 FY2025 |
Anteris Technologies Global Corp. Annual Revenue by Year
Anteris Technologies Global Corp. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.9M).
Anteris Technologies Global Corp. Quarterly Revenue & Net Profit History
Anteris Technologies Global Corp. results over the last 4 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $310.0K | — | $-29.2M | -9420.0% |
| Q3 FY2025 | $429.0K | — | $-22.2M | -5185.1% |
| Q2 FY2025 | $618.0K | — | $-20.8M | -3371.2% |
| Q1 FY2025 | $556.0K | — | $-21.9M | -3932.4% |
Income Statement
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Revenue | $556000 | $618000 | $429000 | $310000 |
| YoY Growth | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Assets | $58.8M | $39.9M | $19.1M | $23.0M |
| Liabilities | $15.7M | $15.8M | $15.7M | $23.3M |
| Equity | $43.3M | $24.4M | $3.7M | $-93000 |
Cash Flow
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Operating CF | $-21.5M | $-19.5M | $-18.3M | $-18.5M |